Orbem

Medical Devices & EquipmentSeries BMunich, Germanyorbem.ai

Latest round

Series B

Last raised

Jan 2026

Total raised

$163M

Investors

11

About Orbem

Based in Munich, Germany, and founded in 2019 by its CEO Pedro Gómez formed as a spin-off from the Technical University of Munich, Orbem GmbH operates as a developer and provider of artificial intelligence (AI) based imaging solutions. Orbem GmbH generates revenue by selling and operating AI-powered MRI systems and analytics for poultry, agriculture and healthcare customers, charging per-scan, subscription and long-term service contracts while expanding datasets that enable recurring, scalable inspection revenues. The company’s imaging solutions specialize in scanning, classifying, and sorting various samples, including food, bio, and other materials, serving the poultry, seed breeding, and nut industries. Orbem’s flagship product is The Genus, an AI-powered imaging platform that utilizes MRI (Magnetic Resonance Imaging) and advanced deep learning algorithms for industrial applications. Some of the detailed applications of the company’s products include the Poultry Industry where Genus offers features such as fertilization status detection, in-ovo sexing, and phenotyping, allowing poultry businesses to optimize production, reduce waste, and increase profitability, and Nut Industry where Genus performs quality control by detecting deformations, discoloration, dehydration, insect bites, damage, and mold in nuts, to enhance the quality assurance, decreases processing costs, and minimizes contamination risks. Additionally, in the Seed breeding sector, the firm’s technology assists in early fault detection and reduces energy consumption by identifying viable seeds at an early stage, hence also improving sustainability and operational efficiency for the seed breeding industry.

Who invested in Orbem

11 investors across 3 rounds

See all investors in Orbem

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Jan 3, 2026

    Amount

    $65M

    Investors

    Locked

  2. Series B

    Jul 30, 2025

    Amount

    $65M

    Investors

    Locked

  3. Series A

    Sep 5, 2023

    Amount

    $32M

    Investors

    Locked

Questions about Orbem

Who invested in Orbem?

Orbem has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Orbem raised?

Orbem has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Orbem last raise money?

Orbem's most recent round on record is a Series B, in Jan 2026.

What does Orbem do?

Based in Munich, Germany, and founded in 2019 by its CEO Pedro Gómez formed as a spin-off from the Technical University of Munich, Orbem GmbH operates as a developer and provider of artificial intelligence (AI) based imaging solutions.

Where is Orbem headquartered?

Orbem is headquartered in Munich, Germany.

Which VCs invest in companies like Orbem?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back medical devices & equipment companies at Orbem's stage. Their profiles are linked below.

Raising like Orbem? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.